Literature DB >> 31107214

National Surveillance of Legionnaires' Disease, China, 2014-2016.

Tian Qin, Hongyu Ren, Dongke Chen, Haijian Zhou, Luxi Jiang, Duorong Wu, Jilu Shen, Fengyan Pei.   

Abstract

We report national surveillance of Legionnaires' disease in China. Urine samples from 11 (3.85%) of 286 patients with severe pneumonia of unknown cause were positive for the Legionella pneumophila serogroup 1 antigen. We isolated Legionella strains from 7 patients. Improved diagnostic testing is needed for this underestimated disease in China.

Entities:  

Keywords:  China; Legionella pneumophila; Legionnaires’ disease; antimicrobial susceptibility; bacteria; molecular subtyping; serogroup

Mesh:

Substances:

Year:  2019        PMID: 31107214      PMCID: PMC6537748          DOI: 10.3201/eid2506.171431

Source DB:  PubMed          Journal:  Emerg Infect Dis        ISSN: 1080-6040            Impact factor:   6.883


Legionnaires’ disease is a form of atypical pneumonia caused by bacteria of the genus Legionella. L. pneumophila serogroup 1 causes most Legionnaires’ disease (). Although Legionnaires’ disease has been reported worldwide, only a few sporadic cases have been reported in China (). Investigation of Legionella infection is urgently needed in China to describe its prevalence and epidemiology. During 2014–2016, we conducted surveillance of Legionnaires’ disease in 18 hospitals in China under the coordination of the Chinese Center for Disease Control and Prevention (China CDC). The Ethical Committee of the National Institute for Communicable Disease Control and Prevention, China CDC (ICDC-2014009), provided ethics approval for this study. The distribution of the 18 hospitals accounted for all regions of China (Appendix Figure 1). The hospital's clinical diagnostic level, pneumonia pathogen detection level, and degree of cooperation with this investigation were also considered. All 18 hospitals are level 3 first-class general hospitals, representing the highest level of healthcare in their cities. The 3,132 severe pneumonia cases were defined and detected according to the Guidelines for the Diagnosis and Treatment of Community-Acquired Pneumonia in Adults in China (2016 edition) () (Appendix Figure 2). Among them, 1,885 cases were diagnosed as noninfectious or nonbacterial infections, and 771 cases were diagnosed as bacterial infections other than Legionella by daily testing, including bacterial culture, viral nucleic acid detection, and immunologic detection in hospital laboratories. Patients with the remaining 476 cases of pneumonia with unknown cause were enrolled and tested for Legionella infection. Among them, 190 left the hospital, died, or were unwilling to cooperate. Thus, urine samples were collected from 286 patients and sent for urine antigen detection for L. pneumophila serogroup 1 (BinaxNow, https://www.alere.com) (Appendix Figure 2). Sputum samples were obtained from 211 of the 286 patients and sent to the laboratory of China CDC (Beijing, China) for Legionella culture, which used both buffered charcoal yeast extract agar and buffered charcoal yeast extract agar supplemented with Legionella GVPC (glycine, vancomycin, polymyxin, cycloheximide) Selective Supplement (Oxoid, https://www.thermofisher.com). Eleven (3.85%) of the 286 urine samples yielded positive results, and we isolated Legionella strains from 7 of them. All 7 L. pneumophila cultures were obtained from the same patients who tested positive by urine antigen detection. The positive rate of Legionella culture was 3.32% (7/211). All isolated Legionella strains were L. pneumophila serogroup 1. All 11 urine antigen–positive patients were male, 23–76 years of age (average 56 years) (Table). They resided in 7 cities, and most (9/11) cases were observed in summer (in China, July–September). All were hospitalized; length of hospitalization ranged from 7 to 93 days. Six were admitted to an intensive care unit. The case-fatality rate was 18.2% (2/11) after antimicrobial and supportive therapies.
Table

Characteristics of 11 Legionnaires’ disease patients, China*

Patient IDAge, yDate of diagnosisOnset cityUnderlying illnessLength of hospitalization, dICU admissionOutcomeSBT type of isolates
1452014 SepShenyangNone15YesRecoveredST2344
2702014 AugBeijingNone93YesRecoveredST59
3532015 AugHefeiNone18NoRecoveredST2369
4632016 JanJinanNone16NoRecoveredST42
5672016 AugHaikouDiabetes21NoRecoveredST742
6232016 JulBeijingAIDS7YesDiedST2366
7532016 SepShanghaiNone14YesRecoveredST2368
8582016 MayLishuiNone8NoRecoveredNS
9492014 JulShenyangCirrhosis14YesDiedNS
10762015 JulBeijingNone17YesRecoveredNS
11592016 SepJinanNone22NoRecoveredNS

*All patients were male. ICU, intensive care unit; ID, identification; NS, no strain isolated; SBT, sequence-based typing; ST, sequence type.

*All patients were male. ICU, intensive care unit; ID, identification; NS, no strain isolated; SBT, sequence-based typing; ST, sequence type. We performed antimicrobial susceptibility testing using E-test strips (bioMérieux, https://www.biomerieux.com). According to the epidemiologic cutoff values of the European Committee on Antimicrobial Susceptibility Testing () or as determined by a previous study (), all 7 strains were susceptible to fluoroquinolones, macrolides, and rifampin but not to cefuroxime (Appendix Table 1). We subtyped the 7 strains using pulsed-field gel electrophoresis () and sequence-based typing (SBT) (). All 7 strains were identified as different pulsed-field gel electrophoresis and SBT types (Appendix Figure 3). Submission to the European Working Group on Legionella Infections L. pneumophila SBT database (http://www.ewgli.org) identified 4 profiles as new; these profiles were assigned new sequence types (STs) (ST2344, ST2366, ST2368, and ST2369). Querying the European Working Group on Legionella Infections database showed that 2 STs (ST42 and ST59) contained strains that are distributed worldwide (Appendix Table 2). We also tested the 7 strains for their intracellular growth ability using previously described methods (), and all showed high intracellular growth in J774 cells, suggesting that these strains are pathogenic (Appendix Figure 4). Many Legionnaires’ disease cases are reported worldwide, including hundreds in the United States and Europe each year (9,). However, no data are available on the prevalence of Legionnaires’ disease in China. In China, no Legionella urine antigen test reagent has been approved for clinical diagnosis and few hospitals conduct Legionella culture, so in clinical laboratories, Legionnaires’ disease is difficult to detect; therefore, diagnosis is based mainly on signs and symptoms. Legionnaires’ disease is usually diagnosed as unexplained pneumonia. The results of this study showed that L. pneumophila is an important pathogen for pneumonia patients in China, and current diagnostic methods in China may misdiagnose or overlook it. We suggest establishment of a routine monitoring reporting system to investigate the prevalence and epidemiology of Legionnaires’ disease in China.

Appendix

Additional information from a study of Legionnaires’ disease surveillance, China, 2014–2016.
  7 in total

1.  Addition of neuA, the gene encoding N-acylneuraminate cytidylyl transferase, increases the discriminatory ability of the consensus sequence-based scheme for typing Legionella pneumophila serogroup 1 strains.

Authors:  Sandra Ratzow; Valeria Gaia; Jürgen Herbert Helbig; Norman K Fry; Paul Christian Lück
Journal:  J Clin Microbiol       Date:  2007-04-04       Impact factor: 5.948

2.  Optimization of pulsed-field gel electrophoresis for Legionella pneumophila subtyping.

Authors:  Haijian Zhou; Hongyu Ren; Bingqing Zhu; Biao Kan; Jianguo Xu; Zhujun Shao
Journal:  Appl Environ Microbiol       Date:  2010-01-08       Impact factor: 4.792

3.  Legionnaires disease in Europe 2007-2008.

Authors:  C A Joseph; K D Ricketts
Journal:  Euro Surveill       Date:  2010-02-25

4.  Wild-type MIC distribution and epidemiological cut-off values in clinical Legionella pneumophila serogroup 1 isolates.

Authors:  Jacob P Bruin; Ed P F Ijzerman; Jeroen W den Boer; Johan W Mouton; Bram M W Diederen
Journal:  Diagn Microbiol Infect Dis       Date:  2011-11-17       Impact factor: 2.803

5.  Legionellosis --- United States, 2000-2009.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2011-08-19       Impact factor: 17.586

Review 6.  Legionella spp. and Legionnaires' disease.

Authors:  B M W Diederen
Journal:  J Infect       Date:  2007-11-05       Impact factor: 6.072

7.  Legionnaires' disease caused by Legionella pneumophila serogroups 5 and 10, China.

Authors:  Qi Zhang; Haijian Zhou; Rong Chen; Tian Qin; Hongyu Ren; Bin Liu; Xinliang Ding; Dan Sha; Weijie Zhou
Journal:  Emerg Infect Dis       Date:  2014-07       Impact factor: 6.883

  7 in total
  3 in total

1.  Incidence, Etiology, and Environmental Risk Factors of Community-Acquired Pneumonia Requiring Hospitalization in China: A 3-Year, Prospective, Age-Stratified, Multicenter Case-Control Study.

Authors:  Tian Qin; Haijian Zhou; Hongyu Ren; Jiantong Meng; Yinju Du; Mahemut Mahemut; Peng Wang; Nana Luo; Fei Tian; Ming Li; Pu Zhou; Fang Li; Pengyuan Duan; Yinan Li; Na Zhao; Qiwu Yuan; Jinzhong Zhang; Lihong Cheng; Longze Luo; Ming Fang; Xin Huang; Changguo Gu; Huifang Zhou; Min Yang; Shan Lu; Xiangkun Jiang; Hualiang Lin; Huaiyu Tian; Biao Kan; Jianguo Xu
Journal:  Open Forum Infect Dis       Date:  2021-10-06       Impact factor: 4.423

2.  Legionella pneumophila Subspecies fraseri Infection after Allogeneic Hematopoietic Stem Cell Transplant, China.

Authors:  Xiaojuan Wang; Yifan Guo; Yawei Zhang; Qi Wang; Shuo Yang; Hua Yang; Tianyi Wang; Hui Wang
Journal:  Emerg Infect Dis       Date:  2022-04       Impact factor: 6.883

3.  Presence of Viable, Clinically Relevant Legionella Bacteria in Environmental Water and Soil Sources of China.

Authors:  Xiao-Yong Zhan; Jin-Lei Yang; Honghua Sun; Xuefu Zhou; Yi-Chao Qian; Ke Huang; Yang Leng; Bihui Huang; Yulong He
Journal:  Microbiol Spectr       Date:  2022-04-19
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.